Coverage for new oral cancer drugs

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2001年 / 15卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：673 / 673
页数：1
相关论文
共 50 条
  • [31] Inequity in insurance coverage for prescription drugs in New Brunswick, Canada
    Ayodele, Busola
    Guo, Elaine Xiaoyu
    Sweetman, Arthur
    Guindon, G. Emmanuel
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2022, 113 (04): : 504 - 518
  • [32] Inequity in insurance coverage for prescription drugs in New Brunswick, Canada
    Busola Ayodele
    Elaine Xiaoyu Guo
    Arthur Sweetman
    G. Emmanuel Guindon
    Canadian Journal of Public Health, 2022, 113 : 504 - 518
  • [33] New trends in the development of oral antidiabetic drugs
    Kecskemeti, V
    Bagi, Z
    Pacher, P
    Posa, I
    Kocsis, E
    Koltai, MZ
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (01) : 53 - 71
  • [34] Caution with New Oral Hepatitis C Drugs
    Soriano, Vicente
    Esposito, Isabella
    AIDS REVIEWS, 2015, 17 (02) : 121 - 122
  • [35] NEW ORAL ANTIDIABETIC DRUGS .2.
    AMBROGI, V
    BLOCH, K
    COZZI, P
    DATURI, S
    LOGEMANN, W
    PARENTI, MA
    TOMMASINI, R
    ARZNEIMITTEL-FORSCHUNG, 1971, 21 (02): : 204 - +
  • [36] Safety of new oral anticoagulant drugs: a perspective
    Antonio Vilchez, Juan
    Gallego, Pilar
    Lip, Gregory Y. H.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2014, 5 (01) : 8 - 20
  • [37] New oral drugs for the treatment of multiple sclerosis
    Chard, Declan
    Trip, Anand
    Chataway, Jeremy
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2016, 77 (09) : 502 - 503
  • [38] New oral anticoagulant drugs in cardiovascular disease
    Ahrens, Ingo
    Lip, Gregory Y. H.
    Peter, Karlheinz
    THROMBOSIS AND HAEMOSTASIS, 2010, 104 (01) : 49 - 60
  • [39] NEW ORAL NONDIGITALIC POSITIVE INOTROPIC DRUGS
    BERDEAUX, A
    COEUR, 1984, 15 (02): : 251 - 260
  • [40] NEW ORAL ANTIDIABETIC DRUGS .3.
    AMBROGI, V
    BLOCH, K
    TOMMASINI, R
    LOGEMANN, W
    PARENTI, MA
    DATURI, S
    ARZNEIMITTEL-FORSCHUNG, 1972, 22 (03): : 542 - +
12345